en
Scientific article
English

Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores?

Published inArthritis care & research, vol. 64, no. 6, p. 817-825
Publication date2012
Abstract

To determine whether adding C-reactive protein, anti-cyclic citrullinated peptide antibodies, rheumatoid factor, N-terminal pro-brain natriuretic peptide (NT-proBNP), oxidized low-density lipoprotein (ox-LDL), or anti-apolipoprotein A-I (anti-Apo A-I) IgG to the Framingham 10-year cardiovascular (CV) risk score (FRS) could improve its CV prognostic accuracy in rheumatoid arthritis (RA).

Keywords
  • Aged
  • Aged, 80 and over
  • Antibodies, Anti-Idiotypic/blood
  • Apolipoprotein A-I/immunology
  • Arthritis, Rheumatoid/blood/complications/diagnosis
  • Biological Markers/blood
  • Cardiovascular Diseases/blood/diagnosis/epidemiology
  • Cohort Studies
  • Female
  • Follow-Up Studies
  • Humans
  • Incidence
  • Lipoproteins, LDL/blood
  • Male
  • Middle Aged
  • Natriuretic Peptide, Brain/blood
  • Peptide Fragments/blood
  • Predictive Value of Tests
  • Prognosis
  • Prospective Studies
  • ROC Curve
  • Retrospective Studies
  • Risk Factors
Citation (ISO format)
FINCKH, Axel et al. Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores? In: Arthritis care & research, 2012, vol. 64, n° 6, p. 817–825. doi: 10.1002/acr.21631
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal2151-464X
619views
0downloads

Technical informations

Creation04/25/2013 1:36:00 PM
First validation04/25/2013 1:36:00 PM
Update time03/14/2023 8:09:26 PM
Status update03/14/2023 8:09:26 PM
Last indexation01/16/2024 1:33:25 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack